He was the first to be named Psychiatrist of the Year by Psychiatric Times, and the first recipient of the Fawcett Humanitarian Award of the NDMDA (now the Depression and Bipolar Support Alliance.
... the same hyperaggressive monkeys who kill each other are also hypersexual ... maybe it isn't just the careless use of the word when people call certain areas of certain cities jungles" (quoted in Medical Apartheid).
A short time after the media scandal, he was reprimanded in the form of being appointed by then DHHS Secretary Sullivan, to head NIMH, a small step down.
The 2007 second edition of Goodwin's Manic Depressive Illness notes in its Acknowledgements that:During the time that this book was in preparation, Dr. Goodwin received research support from George Washington University Medical Center, the Foundation for Education and Research on Mental Illness, the Dalio Family Foundation, GlaxoSmithKline, Pfizer, Eli Lilly, and Solvay.
[10]Goodwin was also on the board of directors of the Center for Medicine in the Public Interest, which the online magazine Slate described as an "industry-funded front ... which receives a majority of its funding from drug companies".
[11] An article in The New York Times (Nov. 21, 2008)[12] said that Goodwin had hosted segments of the National Public Radio program The Infinite Mind that recommended the use of drugs without disclosing that he had received over a million dollars from their manufacturers.
Bill Lichtenstein, the senior executive producer of the show, said that Goodwin had not disclosed payments from pharmaceutical companies, in violation of a strict conflict of interest contract.
Goodwin issued a statement that The New York Times article and the follow-up editorial were filled with misstatements of fact and false implications.
[8] With Kay Redfield Jamison, Goodwin wrote Manic-Depressive Illness, the first psychiatric text to win the "Best Medical Book" award from the Association of American Publishers, which appeared in two editions, 1990 and 2007.